$AZN to discover and develop novel therapies targeting #RNA-modifying proteins in #oncology collaboration with Accent Therapeutics @accent_tx which will receive an upfront payment of $55m

#cancer #stocks #singlestockETPs

https://t.co/Q9bWajKaRj